Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

TSX:ATE - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Back down close to $1

View:

Post by Duster340 on Jan 10, 2024 10:07am

Back down close to $1

dan is going to have to serve up some red meat next week if he wants to get that 6.5M maybe some insider buying would help keep the price up. i do not think p2 will start untill march, that is when it started last time, my guess it will be announced in the march edition of the virtual event series.

(March 29, 2019) – Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer therapeutics for pain and inflammation, is pleased to announce that its Phase 2B dose-ranging, efficacy study for ATB-346 has formally commenced.

279